AHA Advocacy Alliance for the 340B Drug Pricing Program


For more than 20 years, the 340B Drug Pricing Program has provided financial relief to certain safety-net hospitals from high prescription drug costs. Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for uninsured and low-income patients.

The AHA Advocacy Alliance for the 340B Drug Pricing Program works to promote the value the 340B program provides to patients and communities and to oppose any efforts to scale back the program.  Through email communications, conference calls and special briefings, the AHA 340B Advocacy Alliance keeps hospitals informed about the latest news and developments on the program, as well as actions hospital leaders can take to support the program.

TOOLS AND RESOURCES

  RESOURCES 

  AHA NEWS


Return to the Alliances homepage.

 

Search

Case studies on the value of the
340B program

Hospitals are speaking out to show the value that the 340B Drug Pricing Program brings to patients and communities. View the case studies by clicking here.

About AHA

Membership

Member Constituency Sections

Key Relationships

News Center

Performance Improvement

Advocacy Issues

Products & Services

Publications

Research & Trends

Locations

155 N. Wacker Dr.
Chicago, Illinois 60606
312.422.3000

800 10th Street, N.W.
Two CityCenter, Suite 400
Washington, DC 20001-4956
202.638.1100

1.800.424-4301